Metly.ai is a well-funded, AI-native company building the intelligence layer for the pharmaceutical industry. Backed by an oversubscribed pre-seed round from leading European investors and former BMS leadership, we are centralizing fragmented pharma knowledge to help BD&L and portfolio strategy teams automate high-stakes decision-making workflows at market speed.
